期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Role of chemotherapy in stage Ⅱb nasopharyngeal carcinoma 被引量：3

Role of chemotherapy in stage Ⅱb nasopharyngeal carcinoma
暂未订购
导出
摘要 The efficacy of neoadjuvant chemotherapy and adjuvant chemotherapy on stage Ⅱb nasopharyngeal carcinoma (NPC) remains unclear. Conventional two-dimensional radiotherapy combined with concurrent chemotherapy can improve the overall survival, progression-free survival, recurrence-free survival, and distant metastasis-free survival of patients with stage Ⅱb NPC. Intensity-modulated radiotherapy without concurrent chemotherapy also provides good outcomes for patients with stage Ⅱb NPC. This article summarizes the features of stage Ⅱb NPC and reviews the role of chemotherapy in this subgroup of NPC. The efficacy of neoadjuvant chemotherapy and adjuvant chemotherapy on stage lib nasopharyngeal carcinoma（NPC） remains unclear. Conventional two-dimensional radiotherapy combined with concurrent chemotherapy can improve the overall survival, progression-free survival, recurrence-free survival, and distant metastasis-free survival of patients with stage lib NPC. Intensity-modulated radiotherapy without concurrent chemotherapy also provides good outcomes for patients with stage lib NPC. This article summarizes the features of stage lib NPC and reviews the role of chemotherapy in this subgroup of NPC.
作者 Xin-Bin Pan Xiao-Dong Zhu
机构地区 Department of Radiation Oncology
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2012年第12期573-578,共6页
关键词 lib 鼻咽癌 化疗 全国人民代表大会 一阶 生存期 放射治疗 NPC Nasopharyngeal carcinoma, stage lib, chemotherapy
分类号 R739.63 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献35

  • 1赵充,管迅行.鼻咽癌放化综合治疗临床研究现状[J].中华肿瘤防治杂志,2006,13(6). 被引量：36
  • 2孙颖,毛燕萍,马骏,黄莹,唐玲珑,王岩,刘立志,卢泰祥.MRI在鼻咽癌分期中的作用[J].癌症,2007,26(2):158-163. 被引量：23
  • 3Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with Stage Ⅰ - Ⅱ nasopharyngeal carcinoma. Cancer,2003,98:74-80.
  • 4Yi JL, Gao L, Huang XD, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten year experience of a single institution. Int J Radiat Oncol Biol Phys ,2006,65:161-168.
  • 5Lee WM,Sze WM,Au SK,et al. Treatment results for nasopharyn geal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys,2005 ,61:1107-1116.
  • 6Lu TX, Luo W, Zhao C, et al. Retrospective analysis of 934 primary nasopharyngeal carcinoma(NPC) patients treated with conventional external-beam radiotherapy alone. Int J Radiat Oncol Biol Ph,cs ,2004,60:508-509.
  • 7Chua DT, Ma J, Sham JS, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma : subgroup analysis of two phase Ⅲ trials. Int J Radiat Oncol Biol Phys,2006,65:1300-1306.
  • 8Lee AW,Au JK,Teo PM,et al. Staging of nasopharyngeal carcino ma : suggestions for improving the current UICC / AJCC staging system. Clin 0ncol,2004,16:269-276.
  • 9Lu TX, Xiao WW, Han F, et al. Treatment result after radiotherapy alone for patients with early stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys ,2007,69 : 199-200.
  • 10O'Sullivan B. Nasopharynx cancer: therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol Phys,2007,69:118-121.

共引文献220

同被引文献40

  • 1Jakob M, Manz M, Schrck A, et al. Aa3alysis of quality of life outcome for nampharyngeal carcinoma patients after treatment [ J ]. Laryngorhinctologie, 2013, 92 (4) : 244.
  • 2Ferrari D, Chie F, Codeca. C, etal. Loc~regionally ad- vanced nasopharyngeal carcinonm: induction chemotherapy with cisplatin and 5 - fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study [J]. Oncology, 2008, 74(3 4): 158.
  • 3Bae W K, Hwang J E, Shim H J, etal. Phase 1I study of docetaxel, cisplatin,and 5 FU inductkm chemotherapy fol- lowed by chemoradiotherapy in locoregionally advanced na- sopharyngeal cancer [ J ]. Cancer Chemother Pharmacol, 2010, 65(3): 589.
  • 4Ravasco P, Monteiro - Grillo I, Vidal P M, et al. Dietary counselirlg improves patient outcomes: a prospective, ran- domized, controlled trial in coloreetal cancerpatients undergo- ing radiotherapy[J]. J Clin Oncol, 2005, 23(7) : 1431.
  • 5Bauer J D, Capra S. Nutrition intervention improves oul- comes in patients with cancer cachexia receiving chemothera- py- -a pilot study[J].Support Care Cancer, 2005, 13 (4) : 270.
  • 6Huang P Y, Wang C T, Cao K J, et al. Pretreatment body mass index as an independent prognostic factor in patients with Iocoregionally advancednapharyngeaI carcinoma treated with chemoradiotherapy: findings from a randomised trial [J].EurJ Cancer, 2013, 49(8): 1923.
  • 7Qiu C, Yang N, Tian G, et al. Weight loss during radio- therapy for nasopharyngea[ carcinoma: a prospective study from northern China[J]. Nutr Cancer, 2011, 63(6): 873.
  • 8Laouamri S, Hamdi - Cherif M, Sekfali N, et al. Dietary risk factors of nasopharyngeal carcinoma in the Setif area in Algeria[J]. Rev Epidemiol Sante Publique, 2001, 49 (2) : 145.
  • 9Coiffier B, Pro B, Prince HM, et al. Results from a pivotal, open- label, phase Ⅱ study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy[J]. J Clin Oncol, 2012, 30(6) :631-636.
  • 10Lin TS, Ruppert AS, Johnson AJ, et al. Phase Ⅱ study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease [ J ]. J Clin Oncol, 2009, 27(35) :6012-6018.

引证文献3

二级引证文献13

Chinese Journal of Cancer
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部